We examined the role ofT lymphocytes bearing the L3T4 phenotype in acute murine cytomegalovirus (MCMV) infection. In vivo administration of rat IgG2b monoclonal antibody (MAb) GK 1.5 was used to deplete mice of L3T4+ lymphocytes during acute MCMV infection. Unlike the saline-treated controls that resolved their infections, mice receiving the MAb developed persistent and high levels of virus in the salivary gland, lung and spleen. The production of antibody to MCMV was delayed and the titres achieved were markedly less than in the controls. Despite the higher levels of virus replication, there was no increase in mortality seen in animals treated with the MAb. Following intraperitoneal challenge with MCMV, depletion of L3T4+ lymphocytes was protective, increasing the dose of MCMV required to produce death. These data indicate that T lymphocytes of the L3T4 phenotype influence the degree of MCMV replication during acute infection and may contribute to mortality following intraperitoneal virus challenge.
BenjaminR. J.,
CobboldS. P.,
ClarkM. R.,
WaldmannH.1986; Tolerance to rat monoclonal antibodies: implications for serotherapy. Journal of Experimental Medicine 163:1539–1552
BrodyA. R.,
CraigheadJ. E.1974; Pathogenesis of pulmonary cytomegalovirus infection in immunosup-pressed mice. Journal of Infectious Diseases 129:677–689
BullerR. M. L.,
HolmesK. L.,
HuginA.,
FredericksonT. N.,
MorseH. C.1987; Induction of cytotoxic T-cell responses in vivo in the absence of CD4 cells. Nature London: 32877–79
ClassenD. C.,
MorningstarJ. M.,
ShanleyJ. D.1987; Detection of antibody to murine cytomegalovirus by enzyme-linked immunosorbent and indirect immunofluorescence assays. Journal of Clinical Microbiology 25:600–604
CobboldS. P.,
JayasuriyaA.,
NashA.,
ProsperoT. D.,
WaldmannH.1984; Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature London: 312548–551
DialynasD. P.,
QuanZ. S.,
WallK. A.,
PierresA.,
QuintansJ.,
LokenM. R.,
PierresM.,
FitchF. W.1983; Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK 1.5: similarity of L3T4 to the human Leu-3/T4 molecule. Journal of Immunology 131:2445–2451
JacobsonM. A.,
MillsJ.1988; Serious cytomegalovirus disease in the acquired immunodeficiency syndrome: clinical findings, diagnosis, and treatment. Annals of Internal Medicine 108:585–594
JordanM. C.,
ShanleyI. D.,
StevensJ. G.1977; Immunosuppression reactivates and disseminates latent murine cytomegalovirus. Journal of General Virology 37:419–423
LedbetterJ. A.,
RouseR. V.,
MicklemH. S.,
HerzenbergL. A.1980; T cell subsets defined by expression of Lyt-1, 2, 3 and Thy-1 antigens. Two parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. Journal of Experimental Medicine 152:280–295
MercerJ. A.,
SpectorD. H.1986; Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice. Journal of Virology 57:497–504
QuinnanG. V.1985; Cell mediated immunity in cytomegalovirus infections. In The Herpesviruses4121–142RoizmanB.,
LopezC.
New York & London: Plenum Press;
ReddehaseM. I.,
WetlandF.,
MunchK.,
JonjicS.,
LuskeA.,
KoszinowskiU. H.1985; Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. Journal of Virology 55:264–273
ReddehaseM. I.,
BuhringH. J.,
KoszinowskiU. H.1986; Cloned long term cytolytic T-lymphocyte line with specificity for an immediate early membrane antigen of murine cytomegalovirus. Journal of Virology 57:408–412
ReddehaseM. J.,
MutterW.,
MunchK.,
BuhringH. J.,
KoszinowskiU. H.1987; CD8-positive T lymphocytes specific for murine cytomegalovirus immediate early antigens mediate protective immunity. Journal of Virology 61:3102–3108
ReddehaseM. J.,
JonjicS.,
WeilandF.,
MutterW.,
KoszinowskiU. H.1988; Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors. Journal of Virology 62:1061–1065
SelgradeM. K.,
DanielsM. J.,
HuP. C.,
MillerF. J.,
GrahamJ. A.1982; Effects of immunosuppression with cyclophosphamide on acute murine cytomegalovirus infection and virus augmented natural killer activity. Infection and Immunity 38:1046–1055
SeligmannM.,
ChessL.,
FaheyJ. L.,
FauciA. S.,
LachmannP. J. L.,
Age-StehrJ.,
NguJ.,
PinchingA. J.,
RosenF. S.,
SpiraT. J.,
WybranJ.1984; AIDS – an immunologic re-evaluation. New England Journal of Medicine 311:1286–1297
ShanleyJ. D.,
PesantiE. L.1985; The relationship of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection. Journal of Infectious Diseases 151:454–458
ShanleyJ. D.,
JordanM. C.,
StevensJ. G.1981; Modification by adoptive humoral immunity of murine cytomegalovirus infection. Journal of Infectious Diseases 143:231–237
WildeD. B.,
MarrackP.,
KapplerJ. W.,
DialynasD. P.,
FitchF. W.1983; Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK 1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. Journal of Immunology 131:2178–2183
WofsyD.,
SeamanW. E.1986; Analysis of the function of L3T4+ T cells by in vivo treatment with monoclonal antibody to L3T4. Immunology Research 5:97–105
WofsyD.,
MayesD. C.,
WoodcockJ.,
SeamanW. E.1985; Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice. Journal of Immunology 135:1698–1705